The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
the Predictive Value of neutrophil-to Lymphocyte Ratio on Preeclampsia- Eclampsia
Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital
Listed as NCT01856387, this observational or N/A phase trial focuses on Eclampsia and Preeclampsia and remains ongoing. Sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital, it has been updated 12 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Feb 2017 — Aug 2017 [monthly]
Unknown Status NA
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zekai Tahir Burak Women's Health Research and Education Hospital
For direct contact, visit the study record on ClinicalTrials.gov .